Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Jing Ning,Shenyi Jiang,Xiaoxi Li,Yang Wang,Xuhong Deng,Zhiqiang Zhang,Lijie He,Daqing Wang,Youhong Jiang

DOI: https://doi.org/10.1186/s12890-021-01715-z

IF: 3.1

2021-11-22

BMC Pulmonary Medicine

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

respiratory system

What problem does this paper attempt to address?

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Qian-Wen Zheng,Qian-Zhi Ni,Bing Zhu,Xin Liang,Ning Ma,Yi-Kang Wang,Sheng Xu,Hui-Jun Cao,Ji Xia,Feng-Kun Zhang,Er-Bin Zhang,Xiao-Song Qiu,Xu-Fen Ding,Lin Qiu,Xi-Lin Zhang,Zhao-Hui Dong,Zhi-Gang Li,Xue-Li Zhang,Dong Xie,Jing-Jing Li

DOI: https://doi.org/10.1038/s41388-023-02735-1

IF: 8.756

2023-07-26

Oncogene

Abstract:Oncogene, Published online: 25 July 2023; doi:10.1038/s41388-023-02735-1 Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Bin Yi,Tian Wu,Nan Zhu,Yao Huang,Xiaoyu Yang,Lei Yuan,Yingjun Wu,Xiaofei Liang,Xiaoqing Jiang

DOI: https://doi.org/10.1186/s12951-021-00889-2

IF: 10.2

2021-06-12

Journal of Nanobiotechnology

Abstract:An amendment to this paper has been published and can be accessed via the original article.

biotechnology & applied microbiology,nanoscience & nanotechnology
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

Yan Xu,Yuan Li,Jiankang Jin,Guangchun Han,Chengcao Sun,Melissa Pool Pizzi,Longfei Huo,Ailing Scott,Ying Wang,Lang Ma,Jeffrey H. Lee,Manoop S. Bhutani,Brian Weston,Christopher Vellano,Liuqing Yang,Chunru Lin,Youngsoo Kim,A. Robert MacLeod,Linghua Wang,Zhenning Wang,Shumei Song,Jaffer A. Ajani

DOI: https://doi.org/10.1186/s12943-021-01351-5

IF: 37.3

2021-03-25

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Yingying Qian,Shoujie Chai,Zuyu Liang,Yongfang Wang,You Zhou,Xia Xu,Chenchen Zhang,Min Zhang,Jingxing Si,Feiteng Huang,Zhangdan Huang,Wei Hong,Kai Wang

DOI: https://doi.org/10.1186/s12943-019-1093-0

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:After the publication of this work [1],
Correction To: Analysis of Dynamic Molecular Networks for Pancreatic Ductal Adenocarcinoma Progression

Zongfu Pan,Lu Li,Qilu Fang,Yiwen Zhang,Xiaoping Hu,Yangyang Qian,Ping Huang

DOI: https://doi.org/10.1186/s12935-020-01329-1

IF: 6.429

2020-01-01

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.
Correction to: Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma

Guocai Tian,You Fu,Dahe Zhang,Jiang Li,Zhiyuan Zhang,Xi Yang

DOI: https://doi.org/10.1186/s12935-021-01904-0

IF: 6.429

2021-05-04

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Yan Chen,Zhonghu Li,Mengyun Zhang,Bo Wang,Jiaxin Ye,Yang Zhang,Di Tang,Dandan Ma,Weidong Jin,Xiaowu Li,Shuguang Wang

DOI: https://doi.org/10.1186/s13046-021-01902-0

2021-04-16

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Weipu Mao,Keyi Wang,Bin Xu,Hui Zhang,Si Sun,Qiang Hu,Lei Zhang,Chunhui Liu,Shuqiu Chen,Jianping Wu,Ming Chen,Wei Li,Bo Peng

DOI: https://doi.org/10.1186/s12943-021-01459-8

IF: 37.3

2021-12-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression Via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation

Hsinyi Huang,Wenjing Zhang,Yafang Pan,Yijun Gao,Lei Deng,Fuming Li,Fei Li,Xueyan Ma,Shenda Hou,Jing Xu,Peixue Li,Xiaoxun Li,Guohong Hu,Cheng Li,Haiquan Chen,Lei Zhang,Hongbin Ji

DOI: https://doi.org/10.1158/0008-5472.can-21-2379

IF: 11.2

2021-01-01

Cancer Research

Abstract:In the original version of this article (1), there are errors in Figs. 4D and 5B. Specifically, in Fig. 4D, the CRL-5889 DCFH-DA staining image was mistakenly used with the L78 staining image. In addition, the L78 Western blot images of Fig. 5B were erroneously used with the HTB-182 Western blot images. The correct images have been provided, and the errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.
Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis

Lingxiao Qiu,Pan Song,Pingmei Chen,Huaqi Wang,Fangfang Li,Mengxuan Shu,Gen-cheng Gong,Xiangjin Song,Chun Huang,Hongxia Jia,Nana Li

DOI: https://doi.org/10.3389/fonc.2024.1486678

IF: 4.7

2024-09-14

Frontiers in Oncology

Abstract:This article is a correction to: Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis

oncology
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Chenying Lu,Shiji Fang,Qiaoyou Weng,Xiuling Lv,Miaomiao Meng,Jinyu Zhu,Liyun Zheng,Yumin Hu,Yang Gao,Xulu Wu,Jianting Mao,Bufu Tang,Zhongwei Zhao,Li Huang,Jiansong Ji

DOI: https://doi.org/10.1186/s12964-020-00674-y

IF: 7.525

2020-10-22

Cell Communication and Signaling

Abstract:An amendment to this paper has been published and can be accessed via the original article.

cell biology
Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study

Yanrui Liang,Liying Zhao,Hao Chen,Tian Lin,Tao Chen,Mingli Zhao,Yanfeng Hu,Jiang Yu,Hao Liu,Guoxin Li

DOI: https://doi.org/10.1186/s12885-021-08037-7

IF: 4.638

2021-03-23

BMC Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Cheng-Cao Sun,Wei Zhu,Shu-Jun Li,Wei Hu,Jian Zhang,Yue Zhuo,Han Zhang,Juan Wang,Yu Zhang,Shao-Xin Huang,Qi-Qiang He,De-Jia Li

DOI: https://doi.org/10.1186/s13073-021-00834-w

IF: 15.266

2021-02-11

Genome Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

genetics & heredity
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Jihui Chen,Zhipeng Wang,Shouhong Gao,Kejin Wu,Fang Bai,Qiqiang Zhang,Hongyu Wang,Qin Ye,Fengjing Xu,Hong Sun,Yunshu Lu,Yan Liu

DOI: https://doi.org/10.1186/s12935-021-01876-1

IF: 6.429

2021-03-25

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Jing Ning,Shenyi Jiang,Xiaoxi Li,Yang Wang,Xuhong Deng,Zhiqiang Zhang,Lijie He,Daqing Wang,Youhong Jiang

DOI: https://doi.org/10.1186/s12890-021-01549-9

IF: 3.1

2021-06-10

BMC Pulmonary Medicine

Abstract:Abstract Background Glypican 3 (GPC3) is a heparin sulphate proteoglycan whose expression is associated with several malignancies. However, its expression in non-small-cell lung carcinoma (NSCLC) is limited and ambiguous. This study aimed to comprehensively evaluate the expression of GPC3 in NSCLC and develop a risk-score model for predicting the prognosis of NSCLC. Methods The gene expression profiles of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) were downloaded from the UCSC Xena database. Using the limma package, the differentially expressed genes (DEGs) between different comparison groups were analysed and the differential expression of GPC3 was calculated. A functional enrichment analysis was conducted for GPC3 -associated genes using the DAVID tool. For the GPC3 -associated genes shared by the four comparison groups, a protein–protein interaction network was built using the Cytoscape software. After conducting a survival analysis and a Cox regression analysis, the genes found to be significantly correlated with prognosis were selected to construct a risk-score model. Besides, the gene and protein levels of GPC3 were examined by quantitative reverse transcriptase-PCR (qRT-PCR) and immunohistochemistry (IHC) in LUSC tissues and paracancer tissues. Results The differential expression of GPC3 was significant (adjusted P < 0.05) in the NSCLC vs. normal, LUAD vs. normal, LUSC versus normal, and LUAD versus. LUSC comparison groups. GPC3 directly interacted with SERPINA1, MFI2, and FOXM1 . Moreover, GPC3 expression was significantly correlated with pathologic N, pathologic T, gender, and tumour stage in LUAD samples. Finally, the risk-score model (involving MFI2 , FOXM1 , and GPC3 ) for LUAD and that (involving SERPINA1 and FOXM1 ) for LUSC were established separately. The qRT-PCR result showed that GPC3 expression was much higher in the LUSC tissues than that in the normal group. The IHC results further showed that GPC3 is highly expressed in LUSC tissues, but low in paracancer tissues. Conclusion The three-gene risk-score model for LUAD and the two-gene risk-score model for LUSC might be valuable in improving the prognosis of these carcinomas.

respiratory system
Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Dongshan Chen,Chen Zhang,Yuanwei Zang,Wei Wang,Jiandong Zhang

DOI: https://doi.org/10.3389/fgene.2024.1440802

IF: 3.7

2024-06-27

Frontiers in Genetics

Abstract:This article is a correction to: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

genetics & heredity
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Xi Chen,Jishu Guo,Fan Zhou,Wenjun Ren,Xiaobin Huang,Jun Pu,Xiaoqun Niu,Xiulin Jiang

DOI: https://doi.org/10.3389/fonc.2024.1223478

IF: 4.7

2024-09-04

Frontiers in Oncology

Abstract:This article is a correction to: Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

oncology

Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Correction To: Analysis of Dynamic Molecular Networks for Pancreatic Ductal Adenocarcinoma Progression

Correction to: Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma

Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression Via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation

Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma